Stir Fry Kit, Alaska Carrot, 1 x 11 lb. per case, UPC 45009 85749 1 The ingredient: Green cabbage, yellow onion, broccoli florette, c...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (listeria). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0163-2018.
Stir Fry Kit product is recalled due to possible contamination with Listeria monocytogenes. The broccoli used in processing this item has been recalled by vendor Mann Packing of Salinas, California.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0163-2018.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Triple B Corporation or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0163-2018.
Triple B Corporation
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Triple B Corporation Recall FAQ
Triple B Corporation is the subject of a produce safety report: Stir Fry Kit, Alaska Carrot, 1 x 11 lb. per case, UPC 45009 85749 1 The ingredient: Green cabbage, yellow onion, broccoli florette, c.... The notice was published on October 20, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 42 units are potentially affected.